Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Insulin Therapy in Adults with Type 1 Diabetes Mellitus: a Narrative Review
Andrej Janež, Cristian Guja, Asimina Mitrakou, et al.
Diabetes Therapy (2020) Vol. 11, Iss. 2, pp. 387-409
Open Access | Times Cited: 131

Showing 1-25 of 131 citing articles:

Zein nanoparticles for drug delivery: Preparation methods and biological applications
Luís André de Almeida Campos, Azael Francisco Silva Neto, Maria Cecília Souza Noronha, et al.
International Journal of Pharmaceutics (2023) Vol. 635, pp. 122754-122754
Closed Access | Times Cited: 51
Controlled synthesis of in-situ gold nanoparticles onto chitosan functionalized PLGA nanoparticles for oral insulin delivery
Hajar A. Asal, Kamel R. Shoueir, Maha A. El-Hagrasy, et al.
International Journal of Biological Macromolecules (2022) Vol. 209, pp. 2188-2196
Open Access | Times Cited: 45
Type 1 and type 2 diabetes mortality burden: Predictions for 2030 based on Bayesian age‐period‐cohort analysis of China and global mortality burden from 1990 to 2019
Chunping Dong, Guifu Wu, Hui Li, et al.
Journal of Diabetes Investigation (2024) Vol. 15, Iss. 5, pp. 623-633
Open Access | Times Cited: 11
Noninvasive Diabetes Detection through Human Breath Using TinyML-Powered E-Nose
Alberto Gudiño-Ochoa, J A García-Rodríguez, Raquel Ochoa-Ornelas, et al.
Sensors (2024) Vol. 24, Iss. 4, pp. 1294-1294
Open Access | Times Cited: 9
Multifactorial Basis and Therapeutic Strategies in Metabolism-Related Diseases
João Victor da Silva Guerra, Marieli M. G. Dias, Anna Julyana Viana Chianca Brilhante, et al.
Nutrients (2021) Vol. 13, Iss. 8, pp. 2830-2830
Open Access | Times Cited: 48
State of Knowledge on Molecular Adaptations to Exercise in Humans: Historical Perspectives and Future Directions
Kaleen M. Lavin, Paul M. Coen, Liliana C. Baptista, et al.
Comprehensive physiology (2022), pp. 3193-3279
Open Access | Times Cited: 36
Insulin: evolution of insulin formulations and their application in clinical practice over 100 years
Geremia B. Bolli, Alice Cheng, David R. Owens
Acta Diabetologica (2022) Vol. 59, Iss. 9, pp. 1129-1144
Open Access | Times Cited: 25
Engineering a Rapid Insulin Release System Controlled By Oral Drug Administration
Mohamed Mahameed, Shuai Xue, Bozhidar‐Adrian Stefanov, et al.
Advanced Science (2022) Vol. 9, Iss. 9
Open Access | Times Cited: 23
Controlled Interfacial Polymer Self‐Assembly Coordinates Ultrahigh Drug Loading and Zero‐Order Release in Particles Prepared under Continuous Flow
Pei Zhang, Yingxin Liu, Guobing Feng, et al.
Advanced Materials (2023) Vol. 35, Iss. 22
Open Access | Times Cited: 14
Combination Therapy of SGLT 2 Inhibitors and GLP 1 Receptor Agonists for Glycaemic Management through Weight Reduction
Vinod Kumar, V B Amulya, Manjari Sharma, et al.
Journal of Drug Delivery and Therapeutics (2025) Vol. 15, Iss. 1, pp. 142-148
Open Access
Revolutionizing Diabetes Management: A Comparative Analysis of Novel Vaccine Therapies with Conventional Treatments
Sayali Aher, Harshali Jadhav, Snehal Ukhade
Journal of Advanced Chemical Sciences (2025) Vol. 11, Iss. 1, pp. 822-826
Open Access
Relationship of Glucose Molecule and Thyroid Macromolecule Hormones Disorder in Children
Moustapha Hussein, Nadia Ahmed Saleh
Macromolecular Symposia (2025) Vol. 414, Iss. 1
Closed Access
Unveiling Gestational Diabetes: An Overview of Pathophysiology and Management
Rahul Mittal, K. Mohana Prasad, Joana Lemos, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 5, pp. 2320-2320
Open Access
Beyond metformin: the expanding landscape of Type 2 diabetes treatment
Keith Ntokozo Ncube, T D Malange
SA pharmaceutical journal. (2025) Vol. 92, Iss. 1, pp. 30-34
Closed Access
Personalized glucose forecasting for people with type 1 diabetes using large language models
Francisco J. Lara-Abelenda, David Chushig-Muzo, Pablo Peiro-Corbacho, et al.
Computer Methods and Programs in Biomedicine (2025), pp. 108737-108737
Closed Access
An open‐label, multiple ascending dose trial of orally administered insulin Tregopil in patients with type 1 diabetes mellitus to evaluate its pharmacokinetics, pharmacodynamics, safety and tolerability
Esther Latres, Leona Plum‐Mörschel, Sundara Moorthi Nainar Murugesan, et al.
Diabetes Obesity and Metabolism (2025)
Closed Access
Artificial Pancreas Control Strategies Used for Type 1 Diabetes Control and Treatment: A Comprehensive Analysis
Sohaib Mehmood, Imran Ahmad, Hadeeqa Arif, et al.
Applied System Innovation (2020) Vol. 3, Iss. 3, pp. 31-31
Open Access | Times Cited: 35
Current treatment options and challenges in patients with Type 1 diabetes: Pharmacological, technical advances and future perspectives
Federico Boscari, Angelo Avogaro
Reviews in Endocrine and Metabolic Disorders (2021) Vol. 22, Iss. 2, pp. 217-240
Open Access | Times Cited: 30
Hibiscus sabdariffa in Diabetes Prevention and Treatment—Does It Work? An Evidence-Based Review
Daniel Jamrozik, Weronika Borymska, Ilona Kaczmarczyk‐Sedlak
Foods (2022) Vol. 11, Iss. 14, pp. 2134-2134
Open Access | Times Cited: 20
Diabetes mellitus: interdisciplinary medical, surgical and psychological therapeutic approach
Bogdan Socea, Adrian Silaghi, Laura Rebegea, et al.
Journal of Mind and Medical Sciences (2023) Vol. 10, Iss. 2, pp. 217-236
Open Access | Times Cited: 11
Challenges of CRISPR/Cas-Based Cell Therapy for Type 1 Diabetes: How Not to Engineer a “Trojan Horse”
Dmitry S. Karpov, Anastasiia O. Sosnovtseva, S. V. Pylina, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 24, pp. 17320-17320
Open Access | Times Cited: 11
An orally available compound suppresses glucagon hypersecretion and normalizes hyperglycemia in type 1 diabetes
Farzad Asadi, Subhadra C. Gunawardana, Roland E. Dolle, et al.
JCI Insight (2024) Vol. 9, Iss. 2
Open Access | Times Cited: 4
Beyond expected patterns in insulin needs of people with Type 1 Diabetes: Temporal analysis of automated insulin delivery data (Preprint)
Isabella Degen, Kate Robson Brown, Henry W. J. Reeve, et al.
JMIRx Med (2024) Vol. 5, pp. e44384-e44384
Open Access | Times Cited: 4
What are the perceptions and experiences of adults using mobile applications for self-management in diabetes? A systematic review
Kalthum Patail, Hyunjoo Pai, Geva Greenfield, et al.
BMJ Open (2025) Vol. 15, Iss. 1, pp. e086671-e086671
Open Access
Premixed insulin: Advantages, disadvantages, and future
Yan Xia, Yun Hu, Jianhua Ma
World Journal of Diabetes (2025) Vol. 16, Iss. 3
Closed Access
Page 1 - Next Page

Scroll to top